<bill session="114" type="s" number="2641" updated="2018-06-02T07:15:33Z">
  <state datetime="2016-03-03">REFERRED</state>
  <status>
    <introduced datetime="2016-03-03"/>
  </status>
  <introduced datetime="2016-03-03"/>
  <titles>
    <title type="short" as="introduced">Aidan's Law</title>
    <title type="official" as="introduced">A bill to amend the Public Health Service Act, in relation to requiring adrenoleukodystrophy screening of newborns.</title>
    <title type="display">Aidan's Law</title>
  </titles>
  <sponsor bioguide_id="S000148"/>
  <cosponsors>
    <cosponsor bioguide_id="B001267" joined="2016-05-18"/>
    <cosponsor bioguide_id="B001277" joined="2016-06-28"/>
    <cosponsor bioguide_id="G000555" joined="2016-05-26"/>
    <cosponsor bioguide_id="M000702" joined="2016-05-18"/>
  </cosponsors>
  <actions>
    <action datetime="2016-03-03">
      <text>Introduced in Senate</text>
    </action>
    <action datetime="2016-03-03" state="REFERRED">
      <text>Read twice and referred to the Committee on Health, Education, Labor, and Pensions.</text>
    </action>
  </actions>
  <committees>
    <committee subcommittee="" code="SSHR" name="Senate Health, Education, Labor, and Pensions" activity="Referral"/>
  </committees>
  <relatedbills>
    <bill type="h" session="114" relation="identical" number="4692"/>
  </relatedbills>
  <subjects>
    <term name="Health"/>
    <term name="Advisory bodies"/>
    <term name="Child health"/>
    <term name="Health promotion and preventive care"/>
    <term name="Hereditary and development disorders"/>
    <term name="Medical tests and diagnostic methods"/>
    <term name="Neurological disorders"/>
  </subjects>
  <amendments/>
  <summary date="2016-03-03T05:00:00Z" status="Introduced in Senate">Aidan's Law

This bill amends the Public Health Service Act to require hospitals, child care centers, clinics, and similar institutions caring for infants who are 28 days or less of age to administer to such infants a test for adrenoleukodystrophy, a progressive genetic disease that can cause behavioral changes, seizures, and other neurological symptoms.

To be eligible for funds under the Heritable Disorders Program, a state must establish adrenoleukodystrophy testing standards and procedures. These standards and procedures are subject to review and approval by the Advisory Committee on Heritable Disorders in Newborns and Children. The committee must establish standards and procedures for states without approved standards and procedures.</summary>
  <committee-reports/>
</bill>
